These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23406742)

  • 1. Effects of the histamine H₃ receptor antagonist ABT-239 on cognition and nicotine-induced memory enhancement in mice.
    Kruk M; Miszkiel J; McCreary AC; Przegaliński E; Filip M; Biała G
    Pharmacol Rep; 2012; 64(6):1316-25. PubMed ID: 23406742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.
    Provensi G; Costa A; Passani MB; Blandina P
    Neuropharmacology; 2016 Oct; 109():139-147. PubMed ID: 27291828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.
    Kholdebarin E; Caldwell DP; Blackwelder WP; Kao M; Christopher NC; Levin ED
    Eur J Pharmacol; 2007 Aug; 569(1-2):64-9. PubMed ID: 17544392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the histamine H3 receptor antagonist ABT-239 on acute and repeated nicotine locomotor responses in rats.
    Miszkiel J; Kruk M; McCreary AC; Przegaliński E; Biała G; Filip M
    Pharmacol Rep; 2011; 63(6):1553-9. PubMed ID: 22358104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective brain region activation by histamine H₃ receptor antagonist/inverse agonist ABT-239 enhances acetylcholine and histamine release and increases c-Fos expression.
    Munari L; Provensi G; Passani MB; Blandina P
    Neuropharmacology; 2013 Jul; 70():131-40. PubMed ID: 23380305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
    Esbenshade TA; Browman KE; Miller TR; Krueger KM; Komater-Roderwald V; Zhang M; Fox GB; Rueter L; Robb HM; Radek RJ; Drescher KU; Fey TA; Bitner RS; Marsh K; Polakowski JS; Zhao C; Cowart MD; Hancock AA; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2012 Oct; 343(1):233-45. PubMed ID: 22815533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.
    Cowart M; Faghih R; Curtis MP; Gfesser GA; Bennani YL; Black LA; Pan L; Marsh KC; Sullivan JP; Esbenshade TA; Fox GB; Hancock AA
    J Med Chem; 2005 Jan; 48(1):38-55. PubMed ID: 15634000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice.
    Kruk-Słomka M; Budzyńska B; Biała G
    Pharmacol Rep; 2012; 64(5):1066-80. PubMed ID: 23238464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K
    Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease.
    Bitner RS; Markosyan S; Nikkel AL; Brioni JD
    Neuropharmacology; 2011; 60(2-3):460-6. PubMed ID: 21044639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.
    Yildirim E; Connor DA; Gould TJ
    Behav Pharmacol; 2015 Apr; 26(3):241-8. PubMed ID: 25426579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice.
    Bhowmik M; Saini N; Vohora D
    Brain Res; 2014 Sep; 1581():129-40. PubMed ID: 24952295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.
    Buccafusco JJ; Jackson WJ; Terry AV; Marsh KC; Decker MW; Arneric SP
    Psychopharmacology (Berl); 1995 Aug; 120(3):256-66. PubMed ID: 8524972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
    Patel D; Vishwakarma PK; Patel R; Jain NS
    Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
    Khan N; Saad A; Nurulain SM; Darras FH; Decker M; Sadek B
    Behav Brain Res; 2016 Jan; 297():155-64. PubMed ID: 26467607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
    Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.